Old Web
English
Sign In
Acemap
>
authorDetail
>
Robert Henderson
Robert Henderson
National University of Ireland, Galway
Cell
Cancer research
Immunology
Sialyltransferase
Medicine
3
Papers
9
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The CD38 low natural killer cell line KHYG1 transiently expressing CD16 F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide
2020
Cancer Immunology, Immunotherapy
Subhashis Sarkar
Sachin K. S. Chauhan
John Daly
Alessandro Natoni
Heather Fairfield
Robert Henderson
Emma Nolan
Dawn Swan
Jinsong Hu
Michaela R. Reagan
Michael O’Dwyer
Show All
Source
Cite
Save
Citations (8)
Hypersialylation Protects Multiple Myeloma Cells from NK Cell-Mediated Immunosurveillance and This Can be Overcome By Targeted Desialylation Using a Sialyltransferase Inhibitor
2019
Blood
John Daly
Subhashis Sarkar
Alessandro Natoni
Robert Henderson
Dawn Swan
Mattias Carlsten
Michael O’Dwyer
Show All
Source
Cite
Save
Citations (1)
Hypersialylation protects Myeloma cells from NK cell mediated killing and this can be overcome by targeted desialylation using a sialyltransferase inhibitor.
2019
Clinical Lymphoma, Myeloma & Leukemia
John Daly
Subhashis Sarkar
Alessandro Natoni
Robert Henderson
Dawn Swan
Mattias Carlsten
Michael O’Dwyer
Show All
Source
Cite
Save
Citations (0)
1